Lyra Therapeutics Inc (LYRA)

Apr 30, 2025

Lyra Therapeutics Inc (LYRA) expanding its growth trajectory ahead - Sete News

Apr 30, 2025

Apr 30, 2025

Financial Fitness Check: Examining B. Riley Financial Inc (RILY)’s Key Ratios - DWinneX

Apr 30, 2025

Apr 29, 2025

Rhinitis Pipeline 2025: Groundbreaking Clinical Advancements - openPR.com

Apr 29, 2025

Apr 29, 2025

Keeping an Eye on Lyra Therapeutics Inc (LYRA) After Insider Trading Activity - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

Lyra Therapeutics Inc (LYRA) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Apr 29, 2025

Apr 29, 2025

What was Lyra Therapeutics Inc (LYRA)’s performance in the last session? - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Recent Insider Activity Could Benefit Schrodinger Inc (SDGR) - knoxdaily.com

Apr 29, 2025

Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025

Apr 27, 2025

Lyra Therapeutics (LYRA) Expected to Announce Quarterly Earnings on Tuesday - American Banking and Market News

Apr 27, 2025

Apr 25, 2025

iCoreConnect Inc [ICCT] Shares Fall Approximately -87.86% Over the Year - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Lyra Therapeutics Inc [LYRA] Shares Rise 7.02 % on Thursday - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

QBTS Stock Sees Surge of Approximately 14.13% in Last Five Days - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Deckers Outdoor Corp [DECK] Records 200-Day SMA of $160.33 - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Shopify Inc [SHOP] Records 50-Day SMA of $99.94 - knoxdaily.com

Apr 25, 2025

Apr 24, 2025

Analysts Say Lyra Therapeutics Inc (NASDAQ:LYRA) Can Really Get To 0.5 In 12 Months - Marketing Sentinel

Apr 24, 2025

Apr 22, 2025

An Analysis of Lyra Therapeutics Inc (LYRA)’s Potential Price Growth - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

Take off with Lyra Therapeutics Inc (LYRA): Get ready for trading - Sete News

Apr 22, 2025

Apr 21, 2025

Is Lyra Therapeutics Inc (LYRA) worth investing in despite its undervalued state? - uspostnews.com

Apr 21, 2025

Apr 11, 2025

Brokerages Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) Target Price at $1.25 - Defense World

Apr 11, 2025

Apr 08, 2025

Lyra Therapeutics stock hits 52-week low at $0.1 By Investing.com - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

Lyra Therapeutics stock hits 52-week low at $0.1 - Investing.com

Apr 08, 2025

Apr 03, 2025

TCBI Stock Sees Decline of Approximately -2.19% in Last Five Days - knoxdaily.com

Apr 03, 2025

Apr 01, 2025

Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Apr 01, 2025

Mar 31, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 31, 2025

Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline - Investing.com Australia

Mar 28, 2025

Mar 27, 2025

PTCT Stock Sees Decline of Approximately -2.93% in Last Five Days - knoxdaily.com

Mar 27, 2025

Mar 26, 2025

Lyra Therapeutics Inc (LYRA) deserves deeper analysis - uspostnews.com

Mar 26, 2025

Mar 21, 2025

A Closer Look at Lyra Therapeutics Inc (LYRA) Stock Gains - investchronicle.com

Mar 21, 2025

Mar 19, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 - Investing.com India

Mar 18, 2025

Mar 17, 2025

Analysts Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) Target Price at $4.50 - Defense World

Mar 17, 2025

Mar 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $9.33 - Defense World

Mar 17, 2025

Mar 16, 2025

Lyra Therapeutics (NASDAQ:LYRA) Earns “Neutral” Rating from HC Wainwright - Defense World

Mar 16, 2025

Mar 15, 2025

Lyra Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Mar 15, 2025

Mar 13, 2025

Arbor Realty Trust Closes a $1.15 Billion Repurchase Facility to Unwind Two Outstanding Collateralized Loan Obligations - The Manila Times

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

FDA Green Light: Lyra's Nasal Polyp Treatment Advances as 52-Week Data Shows Promise - StockTitan

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c) - TipRanks

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics (LYRA) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 11, 2025

Zevra Therapeutics (ZVRA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 11, 2025

Mar 06, 2025

Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions - Bain Capital

Mar 06, 2025

Mar 03, 2025

Chronic Rhinosinusitis Pipeline 2024: FDA Updates, Therapy - openPR.com

Mar 03, 2025